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Natural killer (NK) cells play a crucial role in the initial response to viral infections but
the mechanisms controlling their activation are unclear. We show a rapid and transient
activation of NK cells that results in the production of IFN-c immediately following
infection with herpes simplex virus type 1 (HSV-1). Activation of NK cells leading to
synthesis of IFN-c was not mediated by a direct interaction with virus but required the
presence of additional cell types and was largely dependent on the cytokine IL-18, but
not IL-12. HSV-1-induced IFN-c expression by NK cells in vitro was impaired in spleen
cultures depleted of CD11c
+ cells. Conversely, coculture of NK cells with virus-exposed
conventional DC or plasmacytoid (p)DC restored the production of IFN-c, indicating
that multiple DC subsets could mediate NK cell activation. While conventional DC
populations stimulated NK cells independently of IL-18, they were less effective than
pDC in promoting NK cell IFN-c expression. In contrast, the potent stimulation of NK
cells by pDC was dependent on IL-18 as pDC from IL-18-deficient mice only activated a
similar proportion of NK cells as conventional DC. These data identify IL-18 as a crucial
factor for pDC-mediated NK cell regulation.
Introduction
Natural killer cells are critical components of the innate
immune system and have key roles in early immune
responses to various tumours and viruses [1]. While the
interaction between NK receptors and ligands expressed
on the surface of target cells has been shown to
modulate the effector function of NK cells [2, 3]
following infection, pro-inflammatory cytokines such
as IL-12 and IL-18 are thought to regulate NK cell
activation [4–6].
Microbial products such as Escherichia coli lipopoly-
saccharide and unmethylated CpG dinucleotides can
induce IL-12 secretion by macrophages and bone
marrow-derived DC [7–10]. Similarly, distinct lineages
of DC isolated from mice can produce IL-12 [11]. In
particular, conventional CD8a
+ DC and plasmacytoid
DC (pDC) populations have been shown to elaborate
IL-12followingviralinfectionorculturewithavarietyof
microbiological stimuli [12–16].
Biologically active IL-18 can be rapidly produced by
cells following the proteolytic cleavage of an inactive
pro-IL-18 precursor [17, 18], which appears to accumu-
late within cells such as DC [19]. While DC are an
Innate immunity
Correspondence: Dr. Andrew G. Brooks, Department of
Microbiology and Immunology, The University of Melbourne,
Melbourne, 3010 Victoria, Australia
Fax: +61-3-9347-1540
e-mail: agbrooks@unimelb.edu.au
Received 9/6/06
Revised 10/1/07
Accepted 16/2/07
[DOI 10.1002/eji.200636362]
Key words:
Cytokines  Dendritic
cells  HSV-1  NK cells
Abbreviations: APC: allophycocyanin  B6: C57BL/6 
MCMV: murine cytomegalovirus  pDC: plasmacytoid DC
Daniel P. Barr et al. Eur. J. Immunol. 2007. 37: 1334–1342 1334
f 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.euimportant source of IL-18 [20, 21], it can also be
expressed by a variety of other cells including astrocytes
and microglia [22], keratinocytes [23], epithelial cells
[24], adipocytes [25] and cells of the adrenal gland and
kidneys [26, 27]. IL-18 has pleiotropic effects that
dependtosome extentonthe cytokinemilieu and acts in
concert with IL-12 to induce IFN-c production by NK
cells [28–30].
Numerous studies using neutralising antibodies or
animals with targeted gene disruptions suggest that
production of both IL-12 and IL-18 is required for
control of certain bacterial, fungal, protozoan and viral
pathogens in mouse models of infection [31, 32].
However, production of both IL-12 and IL-18 during
immune responses is not always required. IL-18-
deficient mice but not IL-12-deficient mice are suscep-
tible to pneumococcal infection [33]. Conversely, while
both cytokines collaborate for the induction of splenic
NK cell IFN-c responses following murine cytomegalo-
virus (MCMV) infection, only IL-12 is required for
hepatic NK cell activity [34]. Here, we show that splenic
NK cells rapidly produce IFN-c following HSV-1
infection via a mechanism largely dependent on the
presence of IL-18, but not IL-12. Moreover, while both
conventional DC and pDC have the capacity to activate
NKcellsinresponsetoHSV-1,weidentifyaroleforIL-18
in the potent pDC-dependent stimulation of IFN-c
production by NK cells.
Results
The in vivo NK cell response following HSV-1
infection is rapid and transient
Depletion of NK cells prior to infection with HSV-1 can
result in elevated viral replication and increased
morbidity and mortality [35–37]. However, the mech-
anisms by which HSV-1 infection induces NK cell
activation in vivo are unclear. We made use of an
intravenous model of HSV-1 infection in C57BL/6 (B6)
mice to better define the events that result in NK cell
activation. Splenocytes isolated from either na ve mice,
mock-infected mice or mice infected 6 h earlier with
10
6 PFU of HSV-1 were cultured for 4 h in the presence
of Brefeldin A and the production of IFN-c by NK cells
was assessed by flow cytometry. Few CD3
– NK1.1
+ NK
cells from na e or mock-infected mice expressed IFN-c
(Fig.1A). In contrast, there was a marked increase in the
proportion of NK cells that produced IFN-c 6 h post-
infection with HSV-1. This response was dose depen-
dent, with greater than 60% of splenic NK cells staining
positively for IFN-c following inoculation with 10
7 PFU
(Fig. 1B) but not dependent on viral replication since a
similar proportion of activated splenic NK cells was
observed when mice were inoculated with UV-inacti-
vated HSV-1 (Fig. 1C).
Tobetter understandthekineticsofNKcellactivation
following HSV-1 infection, the production of IFN-c by
splenic NK cells was assessed at various times up to 24 h
post-infection (Fig.1D). IFN-c production was observed
as early as 2 h post-infection, peaking at 6 h post-
infection before declining to near background levels by
24 h. The kinetics of other parameters that are
characteristic of activated NK cells was also assessed.
The expression of CD69 and the capacity to lyse the NK
cell-sensitive target cell YAC-1 were both increased over
na e and mock-infected controls as early as 6 h post-
infection with HSV-1 (Fig. 2). In contrast to the IFN-c
response, maximal cytotoxicity and CD69 expression on
NK cells was observed 1 day post-infection. Moreover,
while CD69 expression returned to levels observed in
na emicebyday 3,theabilityofsplenocytestolyseYAC-
1 targets remained elevated until 5 days post-infection
(Fig. 2B and C).
Figure 1. Immediate activation of NK cells following intra-
venous infection with HSV-1. Spleens were obtained from
na ve B6 mice or 6 h after B6 mice were injected intravenously
with (A) Vero cell lysate (Mock) or 10
6 PFU of HSV-1, (B)
increasingdosesofHSV-1,(C)Verocelllysate(Mock),10
6 PFUof
HSV-1 or an equivalent amount of UV-inactivated HSV-1, and
the proportion of NK cells producing IFN-c determined by flow
cytometry. (D) Spleens were obtained from na ve, mock-
infected (Vero cell lysate) or HSV-1-infected (10
6 PFU) mice at
the indicated times post-infection and the proportion of NK
cells producing IFN-c determined by flow cytometry. Data in
panel (A) show representative dot plots of IFN-c production by
NK cells, and have been gated on CD3e
– NK1.1
+ lymphocytes.
Data in panels (B) and(C) show themean proportionof NK cells
producing IFN-c ( SD) and are representative of three
independent experiments. Data in panel (D) show the mean
proportion of NK cells producing IFN-c ( SE) from three
independent experiments
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following HSV-1 infection
IL-12 and IL-18 have been shown to activate the
synthesis of IFN-c byNK cells [28–30, 38, 39]. Therefore
we assessed the contributions of IL-12 and IL-18 to the
rapid activation of NK cells following infection with
HSV-1 using mice lacking either IL-12p40 (B6.IL-12
–/–)
or IL-18 (B6.IL-18
–/–). Mice were infected with HSV-1
and 6 h later the production of IFN-c by NK cells was
determined by flow cytometry. NK cells from B6 and
B6.IL-12
–/– mice responded to HSV-1 infection, with
*14% of splenic NK cells expressing IFN-c in both
strains (Fig. 3A). This response was significantly
reduced in IL-18-deficient mice with *4% of NK cells
staining positive for IFN-c protein (p <0.001 compared
to B6 or B6.IL-12
–/– mice).
To further examine the potential roles of IL-12 or
IL-18 in the induction of NK cell activation after
infection, we also assessed the expression of CD69 by
NK cells and lysis of the NK cell-sensitive YAC-1 target
cells by splenocytes from cytokine-deficient mice 1 day
post-infection with 10
6 PFU of HSV-1. In contrast to the
defect in the production of IFN-c observed in B6.IL-18
–/–
mice, the induction of both CD69 and cytotoxicity by NK
cells were similar to that observed in both B6 and
B6.IL-12
–/– mice (Fig. 3B and C). Thus, while IL-12
appeared dispensable for NK cell activation in response
to infection with HSV-1, these data demonstrated a role
for IL-18 in the immediate and transient production of
IFN-c by NK cells following HSV-1 infection in vivo.
To further dissect the mechanisms regulating the
rapid and transient production of IFN-c by NK cells, we
assessed the ability of HSV-1 to stimulate NK cells in
vitro. As observed following in vivo infection, the
addition of HSV-1 to B6 splenocytes rapidly activated
NK cells with *21% of CD3e
– NK1.1
+ cells producing
IFN-c by 8 h (Fig. 4A). The production of IFN-c was
dependent on the addition of virus as few NK cells
produced IFN-c when treated with a mock inoculum
that lacked HSV-1. Furthermore, NK cell activation in
vitro was not dependent on viral replication as the
addition of UV-inactivated HSV-1 to splenocyte cultures
also stimulated the production of IFN-c byNK cells (data
not shown).
Figure 2. The NK cell response to HSV-1 is characterized by
IFN-c production, CD69 expression and increased YAC-1
cytolysis. Splenocytes were prepared from na ve (shaded
column),mock-infected(unfilledcolumns)andHSV-1-infected
(10
6 PFU, filled columns) miceat 6 h and1, 3, 5 and7 days post-
infection. Cells were stained with anti-NK1.1-FITC and anti-
CD3e-APC and the expression of (A) intracellular IFN-c and (B)
cell surface CD69 by NK cells was assessed by flow cytometry.
(C) Spleen cells were incubated with
51Cr-labeled targets at an
effector to target ratio of 100:1 and specific lysis was
determined. Columns represent mean  SD of three mice at
each time point. Data are representative of two independent
experiments.
Figure 3. Rapid synthesis of IFN-c by NK cells in response to
HSV-1 infection is dependent on IL-18 in vivo. Splenocytes were
prepared from B6, B6.IL-12
–/– and B6.IL-18
–/– mice that were
na ve (unfilledcolumns) or infected(A) 6 h, or (B, C) 24 h earlier
with10
6 PFUofHSV-1(filledcolumns).(A) Cellswereincubated
for 4 h in Brefeldin A and then stained with mAb specific for
NK1.1, CD3e and IFN-c. The proportion of IFN-c
+ NK cells was
subsequently determined by flow cytometry. Columns repre-
sent mean  SD of five mice. Data are representative of at least
three independent experiments. (B) Cells were stained with
mAb specific for NK1.1, CD3e and CD69. The expression of
CD69 by NK cells was subsequently determined by flow
cytometry. Columns represent mean  SD of four mice. Data
are representative of three independent experiments. (C)
Spleen cells were incubated with
51Cr-labeled targets at an
effector to target ratio of 100:1 and specific lysis determined.
Columns represent mean  SE of eight mice from two
independent experiments. Statistical significance comparing
results from infected animals is indicated.
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IFN-c production by NK cells, we assessed the ability of
splenic NK cells from B6, B6.IL-18
–/– and B6.IL-12
–/–
micetorespondtoHSV-1invitro.FewNKcells produced
IFN-c after culture with a mock inoculum, regardless of
geneticbackground(Fig.4B).TheproportionofNKcells
from B6.IL-12
–/– splenocytes that produced IFN-c
following the addition of HSV-1 was almost identical
tothe response observed by NK cells from B6 animals. In
contrast, the proportion of NK cells that produced IFN-c
from B6.IL-18
–/– splenocytes did not exceed 10% even
when 10
7 PFU of virus was added to cultures.
The poor response of NK cells from IL-18-deficient
mice suggested that this cytokine is required for optimal
NK cell IFN-c responses following HSV-1 infection.
Alternatively, the impaired response may have resulted
from anintrinsic NKcell defectduetotheirdevelopment
in the absence of IL-18. To discriminate between these
possibilities, congeneically-marked NK cells were pur-
ified from B6.CD45.1 mice and mixed with either B6,
B6.IL-12
–/– or B6.IL-18
–/– splenocytes (all CD45.1
–) and
stimulatedbytheadditionofHSV-1(Fig.4C).Cells were
then stained with anti-CD45.1 mAb and the proportion
of CD45.1
+ cells (i.e. wild-type NK cells) expressing
intracellular IFN-c was assessed. In the absence of HSV-
1, few CD45.1
+ NK cells added to CD45.1
– splenocyte
cultures produced IFN-c. In contrast, IFN-c expression
was evident in NK cells cocultured with HSV-1 and B6
(*20%) or B6.IL-12
–/– (*25%) splenocytes. However,
there was a marked reduction in the proportion of
IFN-c
+ CD45.1
+ NK cells (*9%) after coculture with
IL-18-deficient splenocytes. Thus, the IFN-c response of
B6-derived NK cells to HSV-1 is defective when these
cells are cultured with B6.IL-18
–/– splenocytes.
We then assessed the ability of exogenous IL-18 to
reverse the defective NK cell response observed in IL-18-
deficient splenocytes. Again, in the absence of exogen-
ous IL-18, the proportion of IFN-c-producing NK cells
from cultures of IL-18-deficient splenocytes stimulated
with HSV-1 was significantly reduced as compared to B6
splenocytes (Fig. 4D). Importantly, the addition of both
virus and recombinant IL-18 to splenocytes from
B6.IL-18
–/– mice restored NK cell activation to similar
levels observed for B6 splenocytes. Togethe, the data
suggests that the impaired NK cell response in IL-18-
deficient animals was not due to NK cell dysfunction but
that IL-18 plays a crucial role in the production of IFN-c
by NK cells immediately following HSV-1 infection.
HSV-1-induced IFN-c production is not due to
direct recognition of virus by NK cells
Although the in vivo and in vitro IFN-c response of NK
cells to HSV-1 occurred with remarkable rapidity, it was
markedly dependent on IL-18. This suggested that
activation of NK cells was not the result of a direct
interaction of NK cells with HSV-1 but rather was
dependent on other cell types that could act as a source
of IL-18. To confirm that HSV-1-induced IFN-c produc-
tion by NK cells required additional cells either as a
source of cytokine or to provide crucial cell-to-cell
interactions, NK cells were purified from B6.CD45.1
mice (CD45.1
+) by cell sorting and assessed for their
ability to produce IFN-c following incubation with HSV-
1 alone or HSV-1 in the presence of congenically marked
splenocytes. While purified NK cells did not respond
following the addition of HSV-1, a high proportion of
IFN-c
+ NK cells were observed following culture with
both HSV-1 and congeneic splenocytes (Fig. 5). There-
fore, the rapid production of IFN-c is not induced by a
direct interaction between the virus and NK cells but
requires the presence of other cell types that may
provide crucial cellular interactions or secrete soluble
factors including IL-18.
Figure 4. Crucial role of IL-18 for HSV-1-induced IFN-c
production by NK cells. (A) Splenocytes from na ve mice were
culturedfor8hwithVerocelllysate(Mock)or10
6 PFUofHSV-1.
Cells were then cultured in Brefeldin A for 4 h, stained and the
proportion of IFN-c
+ NK cells determined by flow cytometry.
Representative histograms showing IFN-c production after
gating on CD3e
– NK1.1
+ cells. (B) The proportion of IFN-c
+ NK
cells in cultures of B6 (diamonds), B6.IL-12
–/– (squares) and
B6.IL-18
–/– (triangles) splenocytes after incubation with in-
creasingdosesofHSV-1.(C)PurifiedB6.CD45.1NKcells(510
4)
were cocultured with 10
6 CD45.1
– B6, B6.IL-12
–/– or B6.IL-18
–/–
splenocytes with Mock inoculum or HSV-1. Values represent
theproportionofCD45.1
+IFN-c
+events.(D)IFN-cproductionby
NKcellsinB6(diamonds)andB6.IL-18
–/–(triangles)splenocytes
induced by Mock inoculum (unfilled) or HSV-1 (filled) in the
presence of the indicated concentrations of recombinant
mouse (rm)IL-18. (B–D) Data show mean  SD from triplicate
cultures. All data are representative of at least three indepen-
dent experiments.
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to HSV-1
Given that HSV-1-dependent stimulation of IFN-c
production required the presence of additional cells
found in the spleen, and that a number of DC
populations have been implicated in the activation of
NK cell responses to viral pathogens [7, 40], we
hypothesised that DC could mediate HSV-1-induced
NK cell activation. Consequently, we wished to deter-
mine if freshly isolated DC could promote NK cell IFN-c
production in response to HSV-1 via an IL-18-dependent
mechanism. Tcells from B6 mice or splenic DC (CD11c
+
F4/80
– low-density cells; Fig. 6A insert) from B6,
B6.IL-12
–/– and B6.IL-18
–/– mice were isolated by cell
sorting and assessed for their ability to stimulate IFN-c
production by purified NK cells in vitro. Little evidence
of NK cell activation was observed following culture of
NK cells alone or with purified Tcells in the presence of
HSV-1 or mock inoculum (Fig. 6A). In contrast, DC from
B6 and B6.IL-12
–/– mice stimulated *38% and *33%
of NK cells to produce IFN-c respectively when cultured
in the presence of HSV-1. However, there was a
significant impairment in the HSV-1-induced activation
of purified NK cells following incubation with DC from
B6.IL-18
–/– mice, with only *17% of the cells respond-
ing. The data suggest that DC-derived IL-18 is important
for the rapid production of IFN-c by NK cells following
HSV-1 infection.
To further confirm a role for DC in mediating the
HSV-1-induced production of IFN-c by NK cells, na e B6
splenocytes were stained with anti-CD11c mAb and CD11c
+ cells were depleted from spleen cell prepara-
tions using cell sorting. Following 8 h culture in mock
inoculum or HSV-1, the proportion of IFN-c
+ NK cells in
CD11c-depleted cultures was compared to cultures that
had been cell sorted without the depletion of CD11c
+
cells. As shown in Fig. 6B, while few NK cells produced
IFN-c after 8 h culture in mock inoculum, coculture of
non-depleted splenocytes with HSV-1 stimulated IFN-c
production by *20% of the NK cells. In contrast, the
depletion of CD11c
+ cells from splenocyte cultures
significantly reduced the proportion of NK cells that
produced IFN-c in response to HSV-1 to *13%.
The CD11c antigen can be expressed on cell types
other than DC, including NK cells [41]. To ensure that
the impaired activation of NK cells in CD11c-depleted
spleen cultures was not due to the selective depletion of
CD11c
+NKcells,purifiedcongeneicallymarkedNKcells
from B6.CD45.1 mice were cocultured either with non-
depleted or CD11c-depleted splenocytes (both CD45.1
–)
and then stimulated with HSV-1. Cells were then stained
with anti-CD45.1 mAb and the proportion of CD45.1
+
NK cells expressing intracellular IFN-c was assessed.
Again, the percentage of IFN-c
+ CD45.1
+ NK cells after
coculture with CD11c-depleted splenocytes was de-
Figure 5. HSV-1-induced activation of NK cells in vitro requires
other cell types. Purified CD45.1
+ NK cells (5  10
4) were
cultured for 8 h with Vero cell lysate (Mock) or with 10
6 PFU
HSV-1 in the presence or absence of 10
6 B6 splenocytes
(CD45.1
–). After incubation in Brefeldin A for an additional 4 h,
cells were labelled with anti-CD45.1 to identify purified NK
cells and then assessed for IFN-c production. Values represent
the proportion of CD45.1
+ IFN-c
+ events and are representative
of at least three experiments.
Figure 6. DC-derived IL-18 regulates HSV-1-induced NK cell
activation. (A) Splenic DC werepurified from B6, B6.IL-12
–/– and
B6.IL-18
–/– mice by cell sorting (insert) and incubated with
purified NK cells (1  10
4) with 10
6 PFU HSV-1 (filled columns)
or Vero cell lysate (unfilled columns). Data are shown as mean
 SE. Statistical significance comparing results B6 DC to
cytokine-deficient DC is indicated (n.s., not significant; *p 0.05).
(B) Splenocytes fromB6 miceor splenocytesdepletedofCD11c-
positivecellswereculturedinthepresenceorabsenceofHSV-1
and the proportion of NK cells producing IFN-c determined
(mean  SD) Statistical significance is indicated (*p <0.05). (C)
Purified B6.CD45.1 NK cells were cocultured with CD11c-
depleted and non-depleted splenocytes from B6 and B6.IL-12
–/–
mice in the presence of HSV-1 and then stained with anti-
CD45.1 and anti-IFN-c. Values represent the proportion of
IFN-c
+ CD45.1
+ NK cells determined by flow cytometry.
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(Fig. 6C).
Whilst thesestudies confirmarolefor DCintherapid
production of IFN-c by NK cells following exposure to
HSV-1, they also highlight the ability of splenocytes of
non-DC origin to mediate NK cell activation. No
differences were noted in the ability of CD11c-depleted
splenocytes from B6 and B6.IL-12
–/– mice to induce
IFN-c production by NK cells (Fig. 6C). Together, these
data indicate that DC and cells of non-DC origin can
activate NK cells after exposure to HSV-1, and that IL-12
is not required for these responses.
HSV-1-stimulated plasmacytoid DC, but not
conventional DC, activate NK cells via IL-18
Numerous studies have demonstrated that there are a
number of distinct populations of splenic DC (reviewed
in [11]). To identify which of these populations played a
role inHSV-1-induced activationof NK cells, CD11c
+DC
were purified from the spleens of B6, B6.IL-12
–/– and
B6.IL-18
–/– animals, separated into subsets based on the
expression of CD8a and CD45RA and directly assessed
for their capacity to stimulate IFN-c production by NK
cellsfromB6mice.DCweresortedintopDC(CD45RA
+)
and conventional DC (CD45RA
–), the latter of which
were further separated into CD8a
– (double negative, DN
DC) and CD8a
+ (CD8a
+ DC) (Fig. 7A). Again, few NK
cells produced IFN-c following culture alone or with
purified B6 T cells regardless of whether HSV-1 was
present or not (data not shown). Similarly, in the
absence of HSV-1, coculture of NK cells with purified DC
subsets did not stimulate the production of IFN-c
regardless of genetic background (Fig. 7B–D). In
contrast, virus-exposed CD8a
+ DC obtained from B6
mice stimulated *21% of NK cells to synthesize IFN-c
(Fig. 7B). CD8a
+ DC isolated from either B6.IL-12
–/– or
B6.IL-18
–/– animals stimulated a similar proportion of
NK cells to produce IFN-c in the presence of HSV-1
(Fig. 7B). Purified DN DC from B6, B6.IL-12
–/– or
B6.IL-18
–/– were also equally effective in their ability to
stimulateIFN-cproduction byNKcells inthepresenceof
HSV-1 (Fig. 7C).
While conventional DC populations from B6 mice
stimulated IFN-c production by *25% of NK cells, pDC
obtained from B6 mice potently stimulated IFN-c
production by NK cells with *73% of NK cells staining
positive for IFN-c (Fig. 7D). The pDC from IL-12-
deficient mice stimulated NK cells (*67%) to levels
similar to that observed from B6 animals; however, only
*19% of NK cells stained positive for IFN-c after
coculture with IL-18-deficient pDC. Thus, in the
presence of HSV-1, conventional DC were able to
promote IFN-c production by NK cells via an IL-18-
independent mechanism. In contrast, the potent ability
ofpDCtoinduceIFN-cproductionrequiredthepresence
of IL-18.
Discussion
The secretion of IFN-c by NK cells following viral
infection is thought to be an important mechanism for
limiting the spread of virus prior to the development of
adaptive immunity [4]. Moreover, recent evidence
suggests that IFN-c expression by NK cells may also
be important in the maturation of DC and the induction
of a Th1 type response by CD4
+ T lymphocytes [42, 43].
However, the mechanisms by which viral infections
induce early IFN-c production from NK cells are
incompletely understood. We have shown that a direct
interaction between HSV-1 and NK cells was insufficient
to stimulate the rapid production of IFN-c. Instead,
IFN-c synthesis by NK cells following HSV-1 infection
involved regulation by other cell types such as DC or
macrophages that could serve as a source of IL-18.
Figure 7. HSV-1-induced NK cell activation is mediated by
multiple DC subsets. DC from na ve B6, B6.IL-12
–/– and
B6.IL-18
–/– mice were enriched from splenocytes and stained
with mAb specific for CD11c, CD8a and CD45RA. (A) Repre-
sentativedot plot of CD11c
+ cells from a B6 animal analysed for
expression of CD8a and CD45RA. DC subsets were purified by
sorting of CD11c
+ splenocytes to obtain CD8a
– CD45RA
– (DN
DC), CD8a
+ CD45RA
– (CD8a
+ DC) or CD45RA
+ (pDC). Purified NK
cells (1  10
4) were incubated with (5  10
4) purified (B) CD8a
+
DC, (C) DN DC, or (D) pDC subsets in the presence of 10
6 PFU
HSV-1 (filled columns) or Vero cell lysate (unfilled columns) for
6 to 8 h. Following incubation in Brefeldin A for an additional
4 h, cells were stained with anti-NK1.1 and anti-TCRb. Cells
were then fixed, permeabilised and stained for intracellular
IFN-c, and the proportion of NK cells that expressed IFN-c
determined by flow cytometry. The proportion of IFN-c
+ NK
cells are expressed as mean  SE from three independent
experiments. Statistical significance comparing results from
cultures of NK cells mixed with purified cytokine-deficient DC
subsets to B6 DC subsets is indicated; *p <0.05.
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only partially inhibited NK cell activation, other cells
also appear to mediate this function. Consistent with
this, removal of F4/80
+ cells together with CD11c
+ cells
almost totally abrogated the ability of HSV-1 to induce
IFN-c production by NK cells (data not shown),
suggesting that DC together with macrophages play a
key role in the HSV-1-induced stimulation of NK cells.
Critically both DC and macrophages have been shown to
express IL-18 [6, 20, 21], which has a major role in
augmenting the IFN-c response to HSV-1 by NK cells.
Pro-IL-18 is stored in preformed granules within the
cytoplasm of cells such as DC or macrophages, and thus
may be rapidly converted to its bioactive form [17–19],
which may account for its dominant role during the
initial stages of HSV-1 infection.
IL-18 has been shown to augment IFN-c responses by
NK cells acting in concert with other cytokines such as
type I interferons (IFN-a/b) [44], IL-15, IL-21 [45] and
in particular, IL-12 [28–30]. The synergistic action of
IL-18 in enhancing IL-12-dependent IFN-c production
by NK cells in the spleen has also been described
following systemic MCMV infection in mice [34].
However, the production of IFN-c by NK cells following
with HSV-1 infection did not require IL-12, but was
largely dependent on IL-18.
Early studies examining cross talk between NK cells
and DC identified a role for cell-to-cell contact [42,
46–48]. However the mechanisms underpinning the
recognition of pathogens and the subsequent induction
of innate immune responses by the various lineages of
DC is increasingly complex [49]. There appears a degree
of specialisation in the cytokine responses of particular
DC subsets following infection. Following stimulation
with HSV-1 or MCMV, pDC produce large quantities of
IFN-a/b and IL-12 and hence are thought to be
important regulators of NK cells [15, 16]. Consistent
with this, pDC purified from MCMV-infected mice have
been shown to induce both IFN-c production and
cytotoxicity by na e NK cells [40]. We demonstrated that
pDC exposed to HSV-1 also efficiently stimulated IFN-c
production by NK cells. Moreover, while the ability of
pDC to potently stimulate NK cells has been proposed to
result from the high levels of IFN-a/b and IL-12 secreted
followingviralinfection,wedefinearoleforIL-18inthis
process.Semino etal.[20]havedemonstratedthatIL-18
is largely confined to the synaptic cleft formed between
human DC and NK cells, thus creating localised high
concentrations of IL-18. Our inability to detect IL-18 in
the culture supernatants of HSV-1-stimulated pDC by
ELISA (data not shown) may reflect the polarised
delivery of IL-18 from DC to NK cells.
Andoniou et al [7] have shown that activation of NK
cells by MCMV-infected bone marrow-derived conven-
tional DC is dependent on IL-18 and to a lesser extent
IL-12. In our studies using freshly isolated DC popula-
tions exposed to HSV-1, there was no evidence of a role
for either IL-18 or IL-12 in the activation of NK cells by
conventionalDCsubsets.Thisapparentdiscrepancymay
be due to (i) subtle differences in the phenotype and
function between bone marrow-derived conventional
DC cultured in vitro and conventional DC freshly
isolated from the spleen and/or (ii) differences in the
impact of HSV-1 and MCMV on the function of DC [50,
51]. As pathogens have evolved a diverse array of
strategies to inactivate DC, the evolution of multiple
mechanisms to activate NK cells may be an important
adaptation to ensure robust early innate immune
responses and may even be critical for the generation
of adaptive immunity via NK cell mediated maturation
of DC.
Together, the data indicate a role for IL-18 in the
activation of NK cells following HSV-1 infection. While it
is likely that a number of distinct cell types can mediate
this function, the IL-18-dependent activation of NK cells
following HSV-1 infection appears to be unique to pDC
among splenic DC populations. Moreover, given recent
evidence showing that IL-18 induces the expression of
CCR7 on human NK cells [52], pDC may induce lymph
node homing of NK cells where they can augment the
development of subsequent adaptive immune responses
via the provision of IFN-c.
Materials and methods
Mice
B6 mice, CD45 congeneic B6.SJL-Ptprc
aPep3
b/BoyJ
(B6.CD45.1) mice and mice with targeted gene disruptions
of Il-12p40 (B6.IL-12
–/–) and Il-18 (B6.IL-18
–/–) were housed
in the animal facility of the Department of Microbiology and
Immunology, The University of Melbourne (Melbourne,
Australia). Male mice were used for experiments at 6 to
10 weeks ofage.Allexperimentationwasconductedaccording
to institutional ethical guidelines.
Virus and cytokines
HSV-1 (KOS strain) was propagated and titerd on Vero cells.
For in vivo infections, mice were injected in the tail vein with
10
6 PFU of HSV-1 in 200 lL saline. For mock infections, mice
were injected intravenously with a freeze thaw lysate of Vero
cells in 200 lL saline. For in vitro incubations, splenocytes or
purified populations of cells were cultured in 200 lL of RPMI
supplemented with 10% heat-inactivated FCS, 23.83 g/L
HEPES, 2 mM L-glutamine, 50 lM 2-mercaptoethanol,
100 U/mL of penicillin and 100 lg/mL of streptomycin in
Vero cell lysate, HSV-1 or recombinant mouse IL-18 (MBL) for
6 to 8 h in round-bottom 96-well plates (TPP).
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Single-cell suspensions were incubated in anti-CD16/32
supernatant (2.4G2) and stained with combinations of
peridinin chlorophyll protein-Cy5.5, phycoerythrin-, allophy-
cocyanin- (APC) or FITC-conjugated antibodies to CD3e
(145–2C11), CD8a (53–6.7), CD45.1 (A20), CD45RA/B220
(RA3–6B2), CD49b (DX5), CD69 (H1.2F3), IFN-c (XMG1.2),
NK1.1 (PK136), TCR b chain (H57–597, all BD PharMingen)
and F4/80 (BM8, Caltag).
Samples were sorted on MoFlo (DakoCytomation) and
FACSAria, acquired on FACSCalibur and LSRII flowcytometers
(BD Biosciences) and analysed using FlowJo (Tree Star).
Intracellular cytokine staining was performed as described
previously [37]. For depletion of DC, spleen cells were stained
with APC-conjugated streptavidin after incubation in media
alone or with biotinylated-anti-CD11c (HL3, BD PharMingen).
CellpreparationswerethengatedonAPC-negativesplenocytes
and purified using cell sorting so that <1% APC-positive cells
remained.
Ex vivo NK cell cytotoxicity assay
NK cell cytotoxicity was assayed with a standard chromium
release assayusing YAC-1 targetcells. Percent specific lysis was
calculated as 100  (cpm test sample – cpm spontaneous
release)/(cpm total release – cpm spontaneous release).
Isolation of NK cells and DC
NK cells and T cells were isolated to >95% purity by sorting
splenocytes labelled with anti-NK1.1-FITC or anti-CD49b-FITC
and anti-CD3e-APC. DC were isolated from spleens as
previously described [53]. Briefly, spleens were mechanically
disrupted, digested with collagenase type II (Worthington
Biochemicals) and grade II bovine pancreatic DNase I
(Boehringer-Mannheim), incubated in EDTA and low-density
splenocytes were isolated by centrifugation over a Nycodenz
gradient (Axis-Shield). For whole DC isolation, cells were then
stained with anti-CD11c-FITC (N418) and anti-F4/80-APC and
cell sorted to a purity of >90%. For purification of DC subsets,
non-DC lineages were removed by incubating cells with mAb
specific for CD3 (KT3), Thy-1 (T24/31.7), CD19 (ID6), Gr-1
(RB6–8C5) and erythrocytes (Ter-119), together with sheep
anti-rat IgG-coupled magnetic beads (Dynal). Enriched DC
were then stained with anti-CD11c, anti-CD8a and anti-
CD45RA and sorted by flow cytometry. The purity of DC
subsets was typically >95%.
Statistical analysis
Two-tailed Student's t-test was performed where indicated.
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